Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease
Sponsor: Marianna Amboni
Summary
The present study involves patients with Parkinson Disease (PD) suffering from freezing of gait (FOG) and depressive symptoms. The main aim of the study is evaluating the efficacy of vortioxetine in reducing moderate/severe FOG not responsive to dopaminergic treatment in patients with PD with depressive symptoms.
Official title: An Open Study to Evaluate the Efficacy of Vortioxetine on Freezing of Gait in Patients Affected by Parkinson Disease with Depressive Symptoms
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-02
Completion Date
2027-02
Last Updated
2025-02-06
Healthy Volunteers
No
Interventions
Vortioxetine (tablet)
Vortioxetine will be used with the aim of treating freezing of gait in subjects with Parkinson Disease and depressive symptoms